| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/20/2008 | WO2008031556A2 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions |
| 03/20/2008 | US20080071233 Pharmaceutical compositions |
| 03/20/2008 | US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 03/20/2008 | US20080071065 Fibroblast Growth Factor-Like Polypeptides |
| 03/20/2008 | US20080070964 Opioid receptor active compounds |
| 03/20/2008 | US20080070935 Isoquinoline, Quinazoline and Phthalazine Derivatives |
| 03/20/2008 | US20080070918 Heat Shock Protein-90 (HSP-90) inhibitors; cancer, inflammation, arthritis, angiogenesis, antimalaria, fungal and viral infections; 2-(4-Hydroxy-cyclohexylamino)-4-(3,7,7-trimethyl-5-oxo-5,6,7,8-tetrahydro-4H-cinnolin-1-yl)-benzamide for example; synthesis from corresponding benzonitriles |
| 03/20/2008 | US20080070842 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 03/20/2008 | US20080070837 Variants of human bone morphogenetic proteins and other cysteine knot cytokine proteins with improved properties, including increased expression yield, expression in absence of a pro-domain, increased solubility, increased specific activity, altered receptor, co-receptor, inhibitor specificity |
| 03/20/2008 | US20080070259 Using presence or absence of mutation in metalloenzyme polynucleotides as diagnostic indicator of cardiovascular and neurodegenerative disorders |
| 03/20/2008 | US20080069911 Plant extracts for the treatment of rheumatoid arthritis |
| 03/20/2008 | US20080069903 Electrical producing creams |
| 03/20/2008 | US20080069894 Drug delivery; mixture of reaction product of dextran, dihydrazide and active material; pH adjustment; forming in situ |
| 03/20/2008 | US20080069884 Administered intraarticular into synovial fluid; water soluble |
| 03/20/2008 | US20080069861 Gastrointestinal health |
| 03/20/2008 | US20080069855 Method of inhibiting the formation of adhesions and scar tissue and reducing blood loss |
| 03/20/2008 | US20080069852 Composite containing biocompatible polymer and bone particles |
| 03/20/2008 | US20080069815 Autoimmune diseases; rheumatic arthritis |
| 03/20/2008 | US20080069811 Follicle stimulating hormone (Fsh); bioavailability; drug screening |
| 03/20/2008 | DE69717831C5 Substituierte 2-(2,6-dioxopiperidin-3-yl)-phthalimide und -1-oxoisoindoline und verfahren zur reduzierung des tnf-alpha-spiegels Substituted 2- (2,6-dioxopiperidin-3-yl) -1-oxoisoindoline and -phthalimides and method for reducing the TNF-alpha levels |
| 03/19/2008 | EP1900815A2 In vivo production of small interfering RNAs that mediate gene silencing |
| 03/19/2008 | EP1900753A2 Method of administering therapeutic polypeptides, and polypeptides therefor |
| 03/19/2008 | EP1900739A1 Diazolodiazine derivatives as kinase inhibitors |
| 03/19/2008 | EP1899377A2 Humanised antibodies specific for nogo-a and phrarmaceutical uses thereof |
| 03/19/2008 | EP1899336A1 Cysteine protease inhibitors |
| 03/19/2008 | EP1899314A2 High yield synthesis methods for producing organic salts of strontium |
| 03/19/2008 | EP1898924A1 Methods of treating osteoporosis and secondary hyperparathyroidism using 20-methyl, gemini vitamin d3 compounds |
| 03/19/2008 | EP1562933B1 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 03/19/2008 | EP1545567B1 Medicament comprising mesenchymal stem cells |
| 03/19/2008 | EP1530573B1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 03/19/2008 | EP1432715B1 Pyrimidine derivatives |
| 03/19/2008 | EP1428880B1 Kidney-specific urate transporter and gene thereof |
| 03/19/2008 | EP1362031B1 Pharmaceutically active piperidine derivatives |
| 03/19/2008 | EP1326980B1 Methods of treatment using wisp polypeptides |
| 03/19/2008 | EP1303496B9 Pyrimidine derivatives |
| 03/19/2008 | EP1282437B1 Treatment of cartilage disorders |
| 03/19/2008 | EP1042293B1 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 03/19/2008 | CN101146819A Peptides that increase collagen or hyaluronic acid production |
| 03/19/2008 | CN101146802A Thiadiazole substituted coumarin derivatives and their use as leukotriene biosynthesis inhibitor |
| 03/19/2008 | CN101146542A Risedronate compositions and their methods of use |
| 03/19/2008 | CN101143866A Chlorophyll derivatives, preparation method and application thereof in medical agricultural chemicals |
| 03/19/2008 | CN101143166A Medicine for swelling and relieving pain and its preparation method and application |
| 03/19/2008 | CN101143165A Composition containing cistanche tubulosa and its extract for treating osteoporosis |
| 03/19/2008 | CN101143161A Medicinal composition for treating wounds and its preparation method |
| 03/19/2008 | CN101143160A Kidney tea extract and its preparing process and application |
| 03/19/2008 | CN100375752C Oleanolic acid and its derivative, preparation method and use |
| 03/19/2008 | CN100375750C Oligopolynucleotide of inhibiting activity of necrosin in human tumor |
| 03/19/2008 | CN100375616C Bone strengthening dripping pills with Premena fulva craib as raw material and method for preparing the same |
| 03/19/2008 | CN100375615C Compound drop pills of stramonium and its preparation method |
| 03/18/2008 | US7345151 Antagonists specific for denatured collagen and methods of using same |
| 03/18/2008 | US7345077 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 03/18/2008 | US7345065 Using adrenergic receptors; side effect reduction |
| 03/18/2008 | US7345063 Amides, preparation and therapeutic use as modulators of CCR-receptor activity |
| 03/18/2008 | US7345062 Substituted acylhydroxamic acids and method of reducing TNFαlevels |
| 03/18/2008 | US7345045 Pyrido-pyrimidine compounds as medicaments |
| 03/18/2008 | US7345033 Carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them |
| 03/18/2008 | US7345024 Pharmaceutical preparation, method for its production as well as its use |
| 03/18/2008 | US7344717 Use of erythropoietin in the treatment of rheumatoid arthritis |
| 03/18/2008 | US7344715 Method for treating multiple myeloma |
| 03/18/2008 | CA2380326C Novel 2-decarboxy-2-phosphinico prostaglandin f analogs |
| 03/18/2008 | CA2121689C 1.alpha.,24(s)-dihydroxy vitamin d2, its formation and use |
| 03/13/2008 | WO2008030579A2 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 03/13/2008 | WO2008030158A1 Multimeric heterocyclic compounds useful as neutrophil elastase inhibitors |
| 03/13/2008 | WO2008029829A1 Pyrazolopyridine derivative and phosphodiesterase (pde) inhibitor containing the same as active ingredient |
| 03/13/2008 | WO2008029825A1 Imidazole derivative |
| 03/13/2008 | WO2008029790A1 Novel nucleic acid |
| 03/13/2008 | WO2008029619A1 Ena antisense oligonucleotide having sequence-specific action |
| 03/13/2008 | WO2008029371A1 Pyridin-4-yl derivatives as immunomodulating agents |
| 03/13/2008 | WO2008029370A1 Pyridin-3-yl derivatives as immunomodulating agents |
| 03/13/2008 | WO2008028937A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 03/13/2008 | WO2008028691A1 N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor modulators |
| 03/13/2008 | WO2007128896A3 Protease inhibitor compound, notably papain, cathepsin k and cathepsin b, and a procedure for the purification of protease inhibitor molecules |
| 03/13/2008 | WO2007126363A3 Antisecretory protein for use in the treatment of compartment syndrome |
| 03/13/2008 | WO2007098198A3 Modulation of bone formation |
| 03/13/2008 | WO2007089544A3 Biodegradable non-ophthalmic implants and related methods |
| 03/13/2008 | WO2007082914A3 Method of diagnosis and method of treatment |
| 03/13/2008 | WO2001028491A3 Method and composition for the treatment of dermatologic diseases |
| 03/13/2008 | US20080064764 Isolated nucleic acids; antibody for selective binding; biodrug treating osteoporosis, osteoblast, bone disorders, osteocalcin mediated disorder |
| 03/13/2008 | US20080064747 Prevention of Neutrophil Recruitment |
| 03/13/2008 | US20080064728 Heterocyclic Compounds Useful as Dpp-Iv Inhibitors |
| 03/13/2008 | US20080064722 Agent for promoting interferon-y production |
| 03/13/2008 | US20080064720 Very Late Antigen-4 dependent inflammatory disease; asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, inflammatory skin disorders, autoimmune disorders, or atherosclerosis, inflammatory skin disorder; methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxy-2-propenoate |
| 03/13/2008 | US20080064696 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 03/13/2008 | US20080064688 Anti-inflammatory medicaments |
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/13/2008 | US20080064683 Oral or intraveinous administration of 1,2,3,6-tetrasubstituted pyrido[3,4-b]indoles to inhibit the 5'-untranslated region-dependent translation; ELISA analysis; angiogenesis inhibitors; anticarcinogenic agents; retinopathy, rheumatoid arthritis, psoriasis, atherosclerosis, obesity, macular degeneration |
| 03/13/2008 | US20080064668 Carbon 20 is substituted with methyl or cyclopropyl, carbon 16 is a single or double bond, and carbon 23 is a single, double, or triple bond; side effect reduction; vitamin deficiency; anticarcinogenic antiarthritic agents; immunotherapy; metabolic disorders; gene expression inhibition of ILT3 |
| 03/13/2008 | US20080064633 Preventing fibronectin deposition and fibrosis; phospholipase A2 inhibition; cystic fibrosis |
| 03/13/2008 | US20080063622 Composition and Method for Delivery of BMP-2 Amplifier/Co-Activator for Enhancement of Osteogenesis |
| 03/13/2008 | CA2663091A1 Modulators of interleukin-1 receptor-associated kinase |
| 03/13/2008 | CA2662281A1 N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor modulators |
| 03/13/2008 | CA2662112A1 Imidazole derivatives and their use as cannabinoid type 2 (cb2) receptor modulators |
| 03/13/2008 | CA2662091A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 03/13/2008 | CA2661992A1 Pyrazolopyridine derivative and phosphodiesterase (pde) inhibitor containing the same as active ingredient |
| 03/13/2008 | CA2661315A1 Pyridin-3-yl derivatives as immunomodulating agents |
| 03/13/2008 | CA2661105A1 Pyridin-4-yl derivatives as immunomodulating agents |
| 03/13/2008 | CA2559634A1 Pharmaceutical preparations for the treatment of arthritis |
| 03/12/2008 | EP1897950A2 Human GIL-19/AE289 proteins and polynucleotides encoding same |
| 03/12/2008 | EP1897883A2 Cationic porphyrin derivatives as antibacterial agents |
| 03/12/2008 | EP1897880A1 1,3-benzothiazinone derivative and use thereof |